Dissemination of extended-spectrum β-lactamase-producing enterobacteriaceae in intensive care units of a medical center in Taiwan

Microbial Drug Resistance

Volumn 12, Issue 3, 2006, Pages 203-209

  Wu, Tsu Lan ^a,b   Chia, Ju Hsin ^a,b   Su, Lin Hui ^a,b   Chu, Chishih ^c   Kuo, An Jing ^a   Chiu, Cheng Hsun ^b,d  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c NATIONAL CHIAYI UNIVERSITY   (Taiwan)

^d CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEFTAZIDIME; EXTENDED SPECTRUM BETA LACTAMASE;

ARTICLE; BURN; CONTROLLED STUDY; DISEASE TRANSMISSION; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; EPIDEMIC; ESCHERICHIA COLI; GENETIC RESISTANCE; HUMAN; INTENSIVE CARE; KLEBSIELLA PNEUMONIAE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; STRAIN IDENTIFICATION; TAIWAN;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; GENE TRANSFER, HORIZONTAL; GENOTYPE; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; PLASMIDS;

BACTERIA (MICROORGANISMS); ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE;

EID: 33751219846     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2006.12.203     Document Type: Article

References (37)

1. Bauernfeind, A., and G. Horl. 1987. Novel R-factor-borne β-lactamase conferring resistance to cephalosporins. Infection 15:257-259.
2. Biedenbach, D.J., D.M. Jonhson, and R.N. Jones. 1999. In vitro evaluation of cefepime and other broad-spectrum β-lactams in Taiwan medical centers. The Taiwan Antimicrobial Resistance Study Group. Diag. Microbiol. Infect. Dis. 35:299-305.
3. Bonnet, R., J.L. Sampaio, R. Labia, C. De Champs, D. Sirot, C. Chanal, and J. Sirot. 2000. A novel CTX-M β-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil. Antimicrob. Agents Chemother. 44:1936-1942.
4. Bradford, P.A. 2001. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14:933-4951.
5. Chanawong, A. F.H. M'Zali, J. Heritage, A. Lulitanond, and P.M. Hawkey. 2001. SHV-12, SHV-5, SHV-2a and VEB-1 extended-spectrum β-lactamases in Gram-negative bacteria isolated in a university hospital in Thailand. J. Antimicrob. Chemother. 48:839-852.
6. Chang, F.Y., L.K. Siu, C.P. Fung, M.H. Huang, and M. Ho. 2001. Diversity of SHV and TEM β-lactamases in Klebsiella pneumoniae: gene evolution in northern Taiwan and two novel β-lactamases, SHV-25 and SHV-26. Antimicrob. Agents Chemother. 45:2407-2413.
7. th ed. Approved Standard M2-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
8. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing. Fifteenth informational supplement. M100-S15. Clinical and Laboratory Standards Institute, Wayne, PA.
9. De Gheldre Y., M.J. Struelens, Y. Glupczynski, P. De Mol, N. Maes, C. Nonhoff, H. Chetoui, C. Sion, O. Ronveaux, and M. Vaneechoutte. 2001. National epidemiologic surveys of Enterbacter aerogenes in Belgian hospitals from 1996-1998. J. Clin. Microbiol. 39:889-896.
10. Farmer, J.J., III. 1995. Enterobacteriaceae: introduction and identification. In P.R. Murray, E.J. Baron, M.A. Pfaller, F.C. Tenover, and R.H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington DC, pp. 438-449.
11. Hernandez, J.R., L. Martinez-Martinez, R. Canton, T.M. Coque, A. Pascual, and Spanish Group for Nosocomial Infections (GEIH). 2005. Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain. Antimicrob. Agents Chemother. 49:2122-2125.
12. Hsueh, P.R., Y.C. Liu, D. Yang, J.J. Yan, T.L. Wu, W.K. Huang, J.J. Wu, W.C. Ko, U.S. Leu, C.R. Yu, and K.T. Luh. 2001. Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan. Microb. Drug Resist. 7:373-382.
13. Kado, C.I., and S.T. Liu. 1981. Rapid procedure for detection and isolation of large and small plasmids. J. Bacteriol. 145:1365-1373.
14. Kim, Y. K., H. Pai, H.J. Lee, S.E. Park, E.H. Choi, J. Kim, J.H. Kim, and E.C. Kim. 2002. Bloodstream infections by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob. Agents Chemother. 46:1481-1491.
15. Knothe, H., P. Shah, V. Kremery, M. Antal, and S. Mitsuhashi. 1983. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 11:315-317.
16. Lebessi, E., H. Dellagrammaticas, P.T. Tassios, L.S. Tzouvelekis, S. Ioannidou, M. Foustoukou, and N.J. Legakis. 2002. Extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit in the high-prevalence area of Athens, Greece. J. Clin. Microbiol. 40:799-804.
17. Lee, S.H., J.Y. Kim, S.H. Shin, Y.J. An, Y.W. Choi, Y.C. Jung, H.I. Jung, E.S. Sohn, S.H. Jeong, and K.J. Lee. 2003. Dissemination of SHV-12 and characterization of new AmpC-type β-lactamase genes among clinical isolates of Enterobacter species in Korea. J. Clin. Microbiol. 41:2477-2482.
18. Liu, C.P., N.Y. Wang, C.M. Lee, L.C. Weng, H.K. Tseng, C.W. Liu, C.S. Chiang, and F.Y. Huang. 2004. Nosocomial and community-acquired Enterobacter cloacae bloodstream infection: risk factors for and prevalence of SHV-12 in multiresistant isolates in a medical centre. J. Hosp. Infect. 58:63-77.
19. Liu, P.Y., J.C. Tung, S.C. Ke, and S.L. Chen. 1998. Molecular epidemiology of extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates in a district hospital in Taiwan. J. Clin. Microbiol. 36:2759-2762.
20. Mabilat, C., and S. Goussard. 1993. PCR detection and identification of genes for extended-spectrum β-lactamases. In D.H. Persing, T.F. Smith, F.C. Tenover, and T.J. White (ed.). Diagnostic molecular microbiology: principle and applications. American Society for Microbiology, Washington D.C. pp. 553-559.
21. Ma, L., J. Alba, F.Y. Chang, M. Ishiguro, K. Yamaguchi, L.K. Siu, and Y. Ishii. 2005. Novel SHV-derived extended-spectrum β-lactamase, SHV-57, that confers resistance to ceftazidime but not cefazolin. Antimicrob. Agents Chemother. 49:600-605.
22. Ma, L., F.Y. Chang, C.P. Fung, T.L. Chen, J.C. Lin, P.L. Lu, J.C. Huang, and L.K. Siu. 2005. Variety of TEM-, SHV-, and CTX-M-type β-lactamases present in recent clinical isolates of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae from Taiwan. Microb. Drug Resist. 11:31-39.
23. Ma, L., Y. Ishii, F.Y. Chang, K. Yamaguchi, M. Ho, and L.K. Siu. 2002. CTX-M- 14, a plasmid-mediated CTX-M type extended-spectrum β-lactamase isolated from Escherichia coli. Antimicrob. Agents Chemother. 46:1985-1988.
24. Mulvey, M.R., E. Bryce, D. Boyd, M. Ofner-Agostini, S. Christianson, A.E. Simor, and S. Paton. 2004. Ambler class A extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals. Antimicrob. Agents Chemother. 48:1204-1214.
25. Paterson, D.L., W.C. Lo, A. Von Gottberg, S. Mohapatra, J.M. Casellas, H. Goossens, L. Mulazimoglu, G. Trenholme, K.P. Klugman, R.A. Bonomo, L.B. Rice, M.M. Wagener, J.G. McCormack, and V.L. Yu. 2004. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum β-lactamase production in nosocomial Infections. Ann. Intern. Med. 140:26-32.
26. Perilli, M., E. Dell'Amico, B. Segatore, M.R. de Massis, C. Bianchi, F. Luzzaro, G.M. Rossolini, A. Toniolo, G. Nicoletti, and G. Amicosante. 2002. Molecular characterization of extended-spectrum β-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey. J. Clin. Microbiol. 40:611-614.
27. Rasheed, J.K., C. Jay, B. Metchock, F. Berkowitz, L. Weigel, J. Crellin, C. Steward, B. Hill, A.A. Medeiros, and F.C. Tenover. 1997. Evolution of ESBL resistance (SHV-8) in a strain of E. coli during multiple episodes of bacteremia. Antimicrob. Agents Chemother. 41:647-653.
28. Siu, L.K., P.L. Lu, P.R. Hsueh, F.M. Lin, S.C. Chang, K.T. Luh, M. Ho, and C.Y. Lee. 1999. Bacteremia due to extended-spectrum β-lactamase- producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: clinical features and identification of different plasmids carrying both SHV-5 and TEM-1 genes. J. Clin. Microbiol. 37:4020-4027.
29. Southern, E.M. 1975. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:503-517.
30. Su, L.H., S.H. Leu, Y.P. Chiu, J.H. Chia, A.J. Kuo, C.F. Sun, T.Y. Lin, and T.L. Wu. 2000. Molecular investigation of two clusters of nosocomial bacteraemia caused by multiresistant Klebsiella pneumoniae using pulsed-field gel electrophoresis and infrequent-restriction-site PCR. J. Hosp. Infect. 46:110-117.
31. Wu, T.L., J.H. Chia, L.H. Su, A.J. Kuo, C. Chu, and C.H. Chiu. 2003. Dissemination of extended-spectrum β-lactamase-producing Enterobacteriaceae in pediatric intensive care units. J. Clin. Microbiol. 41:4836-4838.
32. Yan, J.J., W.C. Ko, S.H. Tsai, H.M. Wu, Y.T. Lin, and J.J. Wu. 2000. Dissemination of CTX-M-3 and CMY-2 β-lactamases among clinical isolates of Escherichia coli in southern Taiwan. J. Clin. Microbiol. 38:4320-4325.
33. Yan, J.J., W.C. Ko, and J.J. Wu. 2001. Identification of a plasmid encoding SHV-12, TEM-1, and a variant of IMP-2 metallo-β-lactamase, IMP-8, from a clinical isolate of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45:2368-2371.
34. Yan, J.J., W.C. Ko, J.J. Wu, S.H. Tsai, and C.L. Chuang. 2004. Epidemiological investigation of bloodstream infections by extended spectrum cephalosporin-resistant Escherichia coli in a Taiwanese teaching hospital. J. Clin. Microbiol. 42:3329-3332.
35. Yan, J.J., S.M. Wu, S.H. Tsai, J.J. Wu, and I.J. Su. 2000. Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum β-lactamases and identification of a novel AmpC enzyme (CMY-8) in southern Taiwan. Antimicrob. Agents Chemother. 44:1438-1442.
36. Yu, W.L, P.L. Winokur, R.N. Jones, and H.S. Sader. 2004. Surveillance in Taiwan using molecular epidemiology for extended-spectrum β-lactamase- producing Klebsiella pneumoniae. Infect. Control Hosp. Epidemiol. 25:812-818.
37. Yu, W.L., P.L. Winokur, D.L. Von Stein, M.A. Pfaller, J.H. Wang, and R.N. Jones. 2002. First description of Klebsiella pneumoniae harboring CTX-M β-lactamases (CTX-M-14 and CTX-M-3) in Taiwan. Antimicrob. Agents Chemother. 46:1098-1100.